Affordable Access

deepdyve-link
Publisher Website

The Protective Effects of L-Carnitine and Zinc Oxide Nanoparticles Against Diabetic Injury on Sex Steroid Hormones Levels, Oxidative Stress, and Ovarian Histopathological Changes in Rat.

Authors
  • Majidi, Fatemeh Zahra1
  • Rezaei, Nourollah2, 3
  • Zare, Zohreh4
  • Dashti, Ayat5
  • Shafaroudi, Majid Malekzadeh1, 4
  • Abediankenari, Saeed1, 6
  • 1 Immunogenetic Research Center (IRC), Mazandaran University of Medical Sciences, P.O. Box 48175-1665, Sari, Iran. , (Iran)
  • 2 Immunogenetic Research Center (IRC), Mazandaran University of Medical Sciences, P.O. Box 48175-1665, Sari, Iran. [email protected] , (Iran)
  • 3 Department of Anatomy and Cell Biology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. [email protected] , (Iran)
  • 4 Department of Anatomy and Cell Biology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. , (Iran)
  • 5 Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, I.R., Iran. , (Iran)
  • 6 Immunogenetic Research Center (IRC), Department of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. , (Iran)
Type
Published Article
Journal
Reproductive Sciences
Publisher
SAGE Publications
Publication Date
Sep 29, 2020
Identifiers
DOI: 10.1007/s43032-020-00317-0
PMID: 32989633
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Diabetes mellitus is a common chronic metabolic disorder. This study aimed to investigate the effects of co-treatment with L-carnitine (LC) and zinc oxide nanoparticles (ZnONPs) on serum levels of sex hormones, oxidative stress, and ovarian histopathology in streptozotocin (STZ)-induced diabetic rats. Female Wistar rats (n = 56, 180-220 g) received a single intraperitoneal (IP) injection of STZ (65 mg/kg). They were randomly assigned into the following groups: diabetic group (Dia), Dia+Met group (100 mg metformin/kg/day), Dia+LC group (200 mg/kg/day), Dia+ZnONPs group (10 mg/kg/day), and Dia+LC+ZnONPs group (200 mg LC/kg/day and 10 mg ZnONPs/kg/day). Control group (Ctl) received the same volume of STZ solvent. After 21 days of treatment, blood serum was centrifuged for sex hormone assays. The right ovary was used for biochemical analysis, and the left ovary was fixed in 10% neutral buffered formalin for histological assessment. The levels of estradiol, progesterone, FSH, and LH significantly increased in the Dia+ZnONPs+LC group (P < 0.001) compared with the Dia group. Co-treatment with LC and ZnONPs reduced malondialdehyde and carbonyl protein and increased glutathione, catalase, and superoxide dismutase activities in ovarian tissue compared with the Dia group (P < 0.05). Moreover, the number of all ovarian follicles significantly increased in this group compared with the Dia group (P < 0.05). The results of this study indicated that co-treatment with LC and ZnONPs could preserve ovarian function by increasing sex hormones levels and antioxidant activity and decreasing lipid peroxidation in diabetic rats. Therefore, this compound supplementation may improve ovulation and fertility in people with diabetes mellitus.

Report this publication

Statistics

Seen <100 times